Rocket Lab Stock: Why I’m Buying Back My Biggest Winner Before the Neutron Launch
Rocket Lab stock was, by far, my single biggest winner this year. I built my position around an average price of $60, then sold most of it into strength at $120–150 for a gain of well over 100%. Now, with shares cooled off to around $80, I’m planning to slowly buy back in. This isn’t nostalgia for a past winner — it’s a deliberate thesis built around one specific date on the calendar: the first launch of the Neutron rocket, targeted for the fourth quarter of 2026. Let me lay out the whole plan, including my honest read of the chart.
My Rocket Lab Trade So Far
I’m a believer in taking profits when a position rewards you, and Rocket Lab did exactly that. From an average cost near $60, I rode it up and sold 500 of my 600 shares in the $120–150 range — locking in a triple-digit percentage gain — while keeping 100 shares as a “runner” so I’d stay in the game. That discipline is exactly what let me redeploy proceeds into other holdings earlier this year. Now I want to rebuild the position, but only on my terms and at prices I find attractive.
Why I’m Re-Accumulating Between $80 and $60
My plan is simple: scale in gradually from the current ~$80 area down toward $60, buying in tranches rather than all at once. Here’s my read on the chart, for what it’s worth.
Over the past year, Rocket Lab roughly doubled (up around 123%), but the journey has been wild — the 52-week range runs from about $32 to $151. That’s a stock that can quadruple and then give half of it back. It recently pulled back roughly 45% from its $151 high to the $80 zone. For a name this volatile, trying to nail a single perfect entry is a fool’s errand, which is exactly why a staggered, dollar-cost-averaging approach makes sense to me: it turns the volatility from an enemy into a tool.
But I’ll be honest about the other side, too. At roughly a $46 billion market cap on about $200 million of quarterly revenue, a tremendous amount of future success is already priced into this stock. That’s not a bargain valuation — it’s a bet on the future. So “attractive price” here is relative, and I’m sizing this as a speculative satellite position, not a core holding.
The Catalyst: Neutron’s Q4 2026 First Launch
Everything in my thesis points to one event. Neutron is Rocket Lab’s medium-lift, reusable rocket — a much bigger vehicle than its workhorse Electron, aimed squarely at the lucrative medium-lift market dominated today by SpaceX. Its first flight is targeted for Q4 2026, and the company has already filed FAA launch permits for a debut window running through the end of 2026.
My core view: if Rocket Lab pulls off a successful Neutron debut on schedule, I think the stock can retest its prior high near $150. A working Neutron transforms the company’s revenue potential. That’s the upside I’m positioning for.
The Milestones I’m Watching (A PM’s Approach)
I spent my career as a project manager, so schedule adherence is practically a religion to me. I don’t just hope Neutron launches — I track the milestones the way I’d track a project plan. CEO Peter Beck himself told investors to watch for “items being placed on test stands” as the key sign of progress toward the Q4 launch. Here’s where things stand:
- Engines: The nine Archimedes engines for the first stage are being put through intense vacuum hot-fire testing at NASA’s Stennis Space Center, running on an aggressive around-the-clock schedule. The first engine builds and early burns were already completed back in 2024.
- Airframe and tanks: After a first-stage tank ruptured during pressure testing earlier this year, Rocket Lab redesigned it — switching to an automated fiber-placement process that eliminates the hand-layup defects behind the original failure, improving both strength margins and manufacturability.
- Stage separation and fairing: The interstage separation passed testing under maximum flight loads, and the team is now testing recovery under off-nominal conditions. The distinctive reusable “Hungry Hippo” fairing has completed its thermal protection coating.
- Avionics and launch site: Avionics, communications, and GNC (guidance) software testing is done. Flight avionics and fluid systems are being integrated at the Middle River facility, after which the vehicle moves to the completed Launch Complex 3 in Virginia for integrated testing on the pad.
When real flight hardware starts standing on those test stands and on the pad, that’s my green light that the Q4 schedule is real.
The Business Behind the Bet
The fundamentals give me some cushion while I wait for the catalyst. Rocket Lab posted record Q1 2026 revenue of about $200 million (up roughly 64% year over year) and a record contracted backlog of about $2.2 billion, with a manifest now exceeding 70 missions. Crucially, an anonymous customer pre-booked five dedicated Neutron launches (plus three Electron flights) through 2029 — the first commercial bookings for a rocket that hasn’t even flown yet, which tells you how much demand is lining up. More recently, the company added NASA science missions (the PolSIR and TSIS-2 launches) to its Electron manifest, and it has been acquiring capability through deals like Mynaric (laser comms) and Motiv (space robotics). A growing backlog doesn’t guarantee anything, but it does mean I’m not betting on Neutron in a vacuum.
The Risks I Respect
I refuse to pitch only the bull case, so here are the things that could break this thesis. Neutron’s schedule has already slipped once, and that tank failure is a reminder that rocket development is brutally hard — further delays are very possible. The first Neutron flight won’t even carry a paying customer, and debut rockets fail at a meaningful rate; a failed maiden flight could hit the stock hard. The company is still burning cash and has raised money through equity offerings, so dilution is a real risk. And as I noted, the valuation already assumes a lot goes right. This is a high-risk, speculative position, full stop.
My Plan
So here’s what I’m actually doing: accumulating slowly from ~$80 down toward $60, in tranches, while watching whether Rocket Lab hits its Neutron milestones on schedule. If the timeline holds and hardware keeps landing on those test stands, I’ll keep building. If the schedule slips badly, I’ll have only deployed part of my capital — which is the whole point of going slow. I’m treating it as a small, asymmetric bet, not a position I’d ever bet the house on.
Final Thoughts
Rocket Lab stock gave me my best trade of the year once, and I think it might offer another opportunity as the Neutron launch approaches. But the difference between gambling and investing here is discipline: a defined entry plan, milestone-based monitoring, honest respect for the risks, and modest position sizing. I’m watching the test stands — and my limit orders — very closely.
Investment Disclaimer
This article reflects my personal opinions, trades, and speculation only. It is not financial, investment, tax, or legal advice, and I am not a licensed financial advisor. Rocket Lab is a highly volatile, speculative, pre-Neutron-revenue stock with significant risks including schedule slippage, launch failure, cash burn, dilution, and a valuation that prices in substantial future success. Nothing here is a recommendation to buy or sell, and my opinion on the chart is just that — an opinion, not a forecast. Past performance does not guarantee future results, and all investing carries the risk of loss, including the loss of your entire principal. Please do your own research and consult a qualified, licensed professional before making any investment decision.
